![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ITGA10 |
Gene summary for ITGA10 |
![]() |
Gene information | Species | Human | Gene symbol | ITGA10 | Gene ID | 8515 |
Gene name | integrin subunit alpha 10 | |
Gene Alias | PRO827 | |
Cytomap | 1q21.1 | |
Gene Type | protein-coding | GO ID | GO:0007154 | UniProtAcc | B4E282 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
8515 | ITGA10 | ATC11 | Human | Thyroid | ATC | 3.71e-05 | 7.14e-01 | 0.3386 |
8515 | ITGA10 | ATC12 | Human | Thyroid | ATC | 4.84e-63 | 1.29e+00 | 0.34 |
8515 | ITGA10 | ATC3 | Human | Thyroid | ATC | 5.97e-08 | 6.02e-01 | 0.338 |
8515 | ITGA10 | ATC4 | Human | Thyroid | ATC | 1.29e-70 | 1.46e+00 | 0.34 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Thyroid | ![]() | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis | ||
PTC: Papillary thyroid cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Oral cavity | OSCC | ![]() |
Oral cavity | LP | ![]() |
Oral cavity | EOLP | ![]() |
Oral cavity | NEOLP | ![]() |
Esophagus | HGIN | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003158928 | Thyroid | ATC | cell-substrate adhesion | 195/6293 | 363/18723 | 1.58e-15 | 1.17e-13 | 195 |
GO:0007160111 | Thyroid | ATC | cell-matrix adhesion | 128/6293 | 233/18723 | 1.49e-11 | 5.41e-10 | 128 |
GO:000722919 | Thyroid | ATC | integrin-mediated signaling pathway | 63/6293 | 107/18723 | 7.09e-08 | 1.24e-06 | 63 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
COL1A1 | ITGA10_ITGB1 | COL1A1_ITGA10_ITGB1 | COLLAGEN | Liver | Precancer |
COL1A2 | ITGA10_ITGB1 | COL1A2_ITGA10_ITGB1 | COLLAGEN | Liver | Precancer |
COL4A1 | ITGA10_ITGB1 | COL4A1_ITGA10_ITGB1 | COLLAGEN | Liver | Precancer |
COL4A2 | ITGA10_ITGB1 | COL4A2_ITGA10_ITGB1 | COLLAGEN | Liver | Precancer |
COL4A3 | ITGA10_ITGB1 | COL4A3_ITGA10_ITGB1 | COLLAGEN | Liver | Precancer |
COL4A4 | ITGA10_ITGB1 | COL4A4_ITGA10_ITGB1 | COLLAGEN | Liver | Precancer |
COL6A1 | ITGA10_ITGB1 | COL6A1_ITGA10_ITGB1 | COLLAGEN | Liver | Precancer |
COL6A2 | ITGA10_ITGB1 | COL6A2_ITGA10_ITGB1 | COLLAGEN | Liver | Precancer |
COL6A3 | ITGA10_ITGB1 | COL6A3_ITGA10_ITGB1 | COLLAGEN | Liver | Precancer |
COL1A1 | ITGA10_ITGB1 | COL1A1_ITGA10_ITGB1 | COLLAGEN | THCA | ADJ |
COL1A2 | ITGA10_ITGB1 | COL1A2_ITGA10_ITGB1 | COLLAGEN | THCA | ADJ |
COL4A1 | ITGA10_ITGB1 | COL4A1_ITGA10_ITGB1 | COLLAGEN | THCA | ADJ |
COL4A2 | ITGA10_ITGB1 | COL4A2_ITGA10_ITGB1 | COLLAGEN | THCA | ADJ |
COL4A3 | ITGA10_ITGB1 | COL4A3_ITGA10_ITGB1 | COLLAGEN | THCA | ADJ |
COL6A1 | ITGA10_ITGB1 | COL6A1_ITGA10_ITGB1 | COLLAGEN | THCA | ADJ |
COL6A2 | ITGA10_ITGB1 | COL6A2_ITGA10_ITGB1 | COLLAGEN | THCA | ADJ |
COL6A3 | ITGA10_ITGB1 | COL6A3_ITGA10_ITGB1 | COLLAGEN | THCA | ADJ |
COL9A2 | ITGA10_ITGB1 | COL9A2_ITGA10_ITGB1 | COLLAGEN | THCA | ADJ |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ITGA10 | SNV | Missense_Mutation | c.2081N>G | p.His694Arg | p.H694R | O75578 | protein_coding | tolerated(0.82) | benign(0) | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ITGA10 | SNV | Missense_Mutation | novel | c.2014N>A | p.Glu672Lys | p.E672K | O75578 | protein_coding | deleterious(0.03) | possibly_damaging(0.555) | TCGA-AN-A03X-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ITGA10 | SNV | Missense_Mutation | novel | c.1045G>A | p.Ala349Thr | p.A349T | O75578 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ITGA10 | SNV | Missense_Mutation | c.202N>T | p.Asp68Tyr | p.D68Y | O75578 | protein_coding | tolerated(0.21) | benign(0.02) | TCGA-AN-A0XU-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ITGA10 | SNV | Missense_Mutation | c.661G>A | p.Asp221Asn | p.D221N | O75578 | protein_coding | deleterious(0.04) | possibly_damaging(0.734) | TCGA-AR-A1AR-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unspecific | Docetaxel | PD | |
ITGA10 | SNV | Missense_Mutation | c.1331N>T | p.Arg444Leu | p.R444L | O75578 | protein_coding | tolerated(0.29) | benign(0.021) | TCGA-AR-A5QP-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | |
ITGA10 | SNV | Missense_Mutation | novel | c.3206N>G | p.Val1069Gly | p.V1069G | O75578 | protein_coding | deleterious(0) | benign(0.397) | TCGA-B6-A1KF-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ITGA10 | SNV | Missense_Mutation | novel | c.3206N>G | p.Val1069Gly | p.V1069G | O75578 | protein_coding | deleterious(0) | benign(0.397) | TCGA-BH-A1FH-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
ITGA10 | SNV | Missense_Mutation | novel | c.3206N>G | p.Val1069Gly | p.V1069G | O75578 | protein_coding | deleterious(0) | benign(0.397) | TCGA-D8-A1JA-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | PD |
ITGA10 | SNV | Missense_Mutation | novel | c.3206N>G | p.Val1069Gly | p.V1069G | O75578 | protein_coding | deleterious(0) | benign(0.397) | TCGA-D8-A1X7-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | ChemotherapyHormone Therapy | doxorubicine+cyclophosphamide+tamoxifen | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |